Area of research
Surgery · Oncology
Research interest
Research focused on Furazolidone and Diabetes mellitus, with related work in Hemophagocytic lymphohistiocytosis, Cirrhosis, Stromal cell. Notable publications include 'Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq', 'Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China', and 'Risk factors for at-risk foot and peripheral artery disease among the population with diabetes: A multicommunity-based cross-sectional study'.
Lipid metabolism-related inflammatory indices (LMIIs) and incident peripheral artery diseases (PAD) in patients with type 2 diabetes mellitus (T2DM): a multicohort study from China and the UK biobank
Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq
Risk factors for at-risk foot and peripheral artery disease among the population with diabetes: A multicommunity-based cross-sectional study
IDDF2023-ABS-0075 A prospective, multicenter study of minimal hepatic encephalopathy prevalence and relationship with quality of life in patients with cirrhosis in china
Reactive Hemophagocytic Lymphohistiocytosis Secondary to Ovarian Adenocarcinoma: A Rare Case Report
Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for <i>Helicobacter pylori</i> infection: A multicenter randomized controlled trial in China
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →